Efficacy of convalescent plasma therapy in improving survival in non-immunized COVID-19 patients
Our findings indicate that CP therapy significantly improves survival in non-immunized COVID-19 patients, reinforcing its potential role in settings with limited access to advanced treatments. Future studies should explore CP's mechanisms of action and its integration into broader therapeutic strategies.
Authors
- Tânia Portella Costa (ORCID: https://orcid.org/0000-0002-3465-7444)
- Dayanne Mozaner Bordin (ORCID: https://orcid.org/0009-0007-6936-1508)
- Lucas Blanes (ORCID: https://orcid.org/0000-0003-2929-6696)
- Mateus Nóbrega Aoki (ORCID: https://orcid.org/0000-0001-5166-2897)
Institutions
- Fundação Carlos Chagas (BR)
- Fundação Oswaldo Cruz (BR)
Publication Details
- Journal
- Virology Journal
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1186/s12985-025-02778-8
- Citations
- 1
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico